[Levamisole in the treatment of different forms of herpes zoster] NLM AIDSLINE Important note: Information in this article was accurate in 1983. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Levamisole in the treatment of different forms of herpes zoster]

Zh Nevropatol Psikhiatr. 1983;83(4):511-5. Unique Identifier : AIDSLINE MED/83226634
Smirnov IuK; Shishov AS; Bagrov FI; Rudometov IuP; Sverdlova LL

Abstract: Fifty patients with early stages of herpes zoster (23 patients with the ophthalmic form and 27 with other localizations of the lesion) were treated with levamisol, since it was assumed that the disease is caused by the activation of the varicellazoster virus in association with cellular immunodeficiency. The control group consisted of 63 subjects, including 26 with the ophthalmic form. Beneficial results such as faster skin clearance and fewer days of hospitalization suggest that this agent should be recommended for combined treatment of patients suffering from herpes zoster.
Keywords: Adult Aged Clinical Trials English Abstract Female Herpes Zoster/*DRUG THERAPY Human Levamisole/ADMINISTRATION & DOSAGE/*THERAPEUTIC USE Male Middle Age Ophthalmic Nerve Time Factors CLINICAL TRIAL JOURNAL ARTICLE

KWDadultagedclinicaltrialsenglishabstractfemaleherpeszoster/KWDdrugtherapyhumanlevamisole/administration&dosage/KWDtherapeuticusemalemiddleageophthalmicnervetimefactorsclinicaltrialjournalarticle
830930
M8390027

Copyright © 1983 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1983. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1983. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .